I disagree. I think the fact that $ATNF is so undevalued at the moment, creates a unique buying opportunity.  There's pretty much no where to go but up.  My only concern is that I'd really like more info on the regulatory concerns. Dr. James Woody was impressively forthcoming that the regulators were concerned that Adalimumab may not effectively treat the disease. That's a big deal.  I'd love to hear more about this White Paper the company created in response to alleviate those concerns.  Is it publicly available?  To me, that makes all the difference and if convincing, I would jump on this stock.

This little darling is certainly under the radar. The CEO makes a good impression and very good case for this stock. At the current price, it's hard to not want to plunge in and see how high it goes. $ATNF

Agreed. $ATNF has a MASSIVE growth potential. The people created Humira for god sake. A 9 billion dollar drug. And they have blockbuster one of a kind drugs In the pipeline. I didn’t even hear about this on Reddit.

I do however think #Occugen is trash. In 1 year there will be too much herd immunity. Once the need for vaccine cools off it will plummet. $OCGN.

Completely disagree. $ATNF is a great buy.